Showing 3611-3620 of 7016 results for "".
Early Detection of Alzheimer's: Where Do We Go From Here?
https://reachmd.com/programs/advances-in-long-term-care-medicine/early-detection-of-alzheimers-where-do-we-go-from-here/6015/Early detection of various conditions can help physicians better manage and treat their patients, and Alzheimer's is no exception. What early screening tests of cognitive impairment or dementia should be administered by primary care providers help detect when the disease process is beginning? Dr. JaUMMA Clinic: Bridging Cultural Divides Through Health Care
https://reachmd.com/programs/clinicians-roundtable/umma-clinic-bridging-cultural-divides-through-health-care/4615/In 1992, after the verdict was handed down in the Rodney King trial, there were six days of rioting in south Los Angeles. Thousands were injured, more than 50 people were killed, and the city saw approximately one billion dollars in property damage. One of the few bright spots during this dark timeDiagnosing and Managing Childhood Food Allergies
https://reachmd.com/programs/hot-topics-in-allergy/diagnosing-and-managing-childhood-food-allergies/3918/Because more children now live with food allergies than in decades past, at what point should a physician suspect that a patient might have a food allergy? What gastrointestinal symptoms are most common in children with food allergies? Dr. Scott Sicherer, associate professor of pediatrics at Mount SBladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
https://reachmd.com/programs/clinicians-roundtable/bladders-breakthroughs-and-bold-new-therapies-key-updates-at-aua-2025/33040/In an exciting time for diagnostics and therapeutics in urology, the discussions at the American Urological Association’s 2025 Annual Meeting are redefining the landscape of men’s health. Dr. Wayne Kuang, CEO of MD for Men in Albuquerque and Founder of the ManVsProstate campaign, highlights some ofLupus Management Considerations for African American Patients
https://reachmd.com/programs/everyday-family-medicine/lupus-management-considerations-for-african-american-patients/10132/With more African Americans experiencing severe lupus symptoms, Drs. Jennifer Caudle and Ashira Blazer provide some much-needed treatment advice.Updates on New Technologies and Imaging Agents in Healthcare
https://reachmd.com/programs/project-oncology/updates-on-new-technologies-and-imaging-agents-in-healthcare/24058/What should we know about the use of AI in practice? Tune in.Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings from the MAPLE-MS Pharmacovigilance Program
https://reachmd.com/programs/neurofrontiers/pregnancy-and-infant-outcomes-in-multiple-sclerosis-findings-from-the-maple-ms-pharmacovigilance-program/36358/Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
https://reachmd.com/programs/cme/Case-in-Point-Applying-PI3K-Combinations-in-Early-Recurrent-HR-HER2-mBC/37336/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/destiny-breast11-neoadjuvant-care-her2-positive-breast-cancer/39722/The DESTINY-Breast11 trial explored a neoadjuvant treatment approach for patients with high-risk, HER2-positive early-stage breast cancer. This phase III study compared standard chemotherapy with regimens incorporating T-DXd, aiming to optimize efficacy while potentially reducing toxicity. Hear Dr.MOA: CDH6-Targeted Antibody-Drug Conjugates
https://reachmd.com/programs/cme/MOA-cdh6-targeted-antibody-drug-conjugates/37668/CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer